OTC - ACTIVE INGREDIENT SECTION
Active Ingredients
Lidocaine HCL 4% w/w
Menthol 1% w/w
Active Ingredients
Lidocaine HCL 4% w/w
Menthol 1% w/w
Purpose
Topical analgesic
Topical analgesic
USES For temporary relief of pain.
Warnings
For external use only. Avoid contact with eyes.
Do not use in large quantities, particularly over raw surfaces, or blistered areas.
Stop use and ask a doctor if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days.
Keep out of reach of children, if swallowed, get medical help or contact a Poison Control Center right away.
If pregnant or breast feeding, ask a health professional.
Directions adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily.
Children under 2 years of age: consult a doctor.
Other Information
store in a cool dry place between (59-86°F) 15-30°C
don't use if seal over cap is broken, torn or missing
Inactive Ingredients
Aloe Barbadensis Leaf Extract, Arnica Extract, Bromelain, C13-14 Isoparaffin, Caprylyl Glycol, Capsicum Annuum Fruit Extract, Chamomile Extract, Devil’s Claw Extract, Dimethicone, Dimethyl Sulfone (MSM), Eucalyptus Oil, Glucosamine Sulfate, Glycerin, Glyceryl Stearate, Glycol Stearate, Horse Chestnut Extract, Isopropyl Myristate, Laureth-7, Lemon Balm Extract, Linden Flower Extract, Menthyl Lactate, PEG-100 Stearate, Phenoxyethanol, Polyacrylamide, Rosemary Extract, Sweet Almond Oil, Water, Willow Bark Extract
Questions or comments
info@aromalief.com
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 72393-204 | 72393-204-25 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 236d66c0-4247-935e-e063-6394a90af9fa | dc01c0fe-12a7-5e28-e053-2a95a90a20e2 | 2024-10-01 | Warnings | dc01c0fe-12a7-5e28-e053-2a95a90a20e2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.